These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30690223)

  • 21. Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sample.
    Belcher J; Nielsen S; Campbell G; Bruno R; Hoban B; Larance B; Lintzeris N; Degenhardt L
    Drug Alcohol Rev; 2014 Jan; 33(1):27-32. PubMed ID: 24251668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diversion and injection of a buprenorphine-naloxone soluble film formulation.
    Larance B; Lintzeris N; Ali R; Dietze P; Mattick R; Jenkinson R; White N; Degenhardt L
    Drug Alcohol Depend; 2014 Mar; 136():21-7. PubMed ID: 24461476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Not what the doctor ordered: Motivations for nonmedical prescription drug use among people who use illegal drugs.
    May T; Holloway K; Buhociu M; Hills R
    Int J Drug Policy; 2020 Aug; 82():102823. PubMed ID: 32585584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What factors contributed to the misconduct of health practitioners? An analysis of Australian cases involving the diversion and supply of pharmaceutical drugs for non-medical use between 2010 and 2016.
    Hulme S; Hughes CE; Nielsen S
    Drug Alcohol Rev; 2019 May; 38(4):366-376. PubMed ID: 30887600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms.
    Johnson B; Richert T
    J Subst Abuse Treat; 2015 Jul; 54():50-5. PubMed ID: 25744650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.
    Inciardi JA; Surratt HL; Kurtz SP; Cicero TJ
    Pain Med; 2007 Mar; 8(2):171-83. PubMed ID: 17305688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adulterants and altruism: A qualitative investigation of "drug checkers" in North America.
    Palamar JJ; Acosta P; Sutherland R; Shedlin MG; Barratt MJ
    Int J Drug Policy; 2019 Dec; 74():160-169. PubMed ID: 31610451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
    Broséus J; Morelato M; Tahtouh M; Roux C
    Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the structure and operation of drug supply chains: The case of cocaine and heroin in Italy and Slovenia.
    Caulkins JP; Disley E; Tzvetkova M; Pardal M; Shah H; Zhang X
    Int J Drug Policy; 2016 May; 31():64-73. PubMed ID: 26997542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rx for a party: a qualitative analysis of recreational pharmaceutical use in a collegiate setting.
    Quintero G
    J Am Coll Health; 2009; 58(1):64-70. PubMed ID: 19592355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deception for drugs: self-reported "doctor shopping" among young adults.
    Stogner JM; Sanders A; Miller BL
    J Am Board Fam Med; 2014; 27(5):583-93. PubMed ID: 25201928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motivations for Selling Ecstasy among Young Adults in the Electronic Dance Music Club Culture in Brazil.
    Remy LS; Buttram ME; Kurtz SP; Surratt HL; Pechansky F
    J Psychoactive Drugs; 2017; 49(5):420-426. PubMed ID: 28692339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of prescription medication diversion among drug dealers.
    Rigg KK; Kurtz SP; Surratt HL
    Drugs (Abingdon Engl); 2012; 19(2):144-155. PubMed ID: 22665955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional changes in an Australian high-level drug trafficking network after exposure to supply changes.
    O'Reilly MJA; Hughes CE; Bright DA; Ritter A
    Int J Drug Policy; 2020 Oct; 84():102797. PubMed ID: 32763755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking.
    Bardwell G; Boyd J; Arredondo J; McNeil R; Kerr T
    Drug Alcohol Depend; 2019 May; 198():1-6. PubMed ID: 30856370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
    Johnson B; Richert T
    Int J Drug Policy; 2015 Feb; 26(2):183-90. PubMed ID: 25465344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia.
    Degenhardt L; Black E; Breen C; Bruno R; Kinner S; Roxburgh A; Fry C; Jenkinson R; Ward J; Fetherston J; Weekley J; Fischer J
    Drug Alcohol Rev; 2006 Sep; 25(5):403-12. PubMed ID: 16939934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users.
    Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L
    Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-ingestion of energy drinks with alcohol and other substances among a sample of people who regularly use ecstasy.
    Peacock A; Sindicich N; Dunn M; Whittaker E; Sutherland R; Entwistle G; Burns L; Bruno R
    Drug Alcohol Rev; 2016 May; 35(3):352-8. PubMed ID: 26424666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma.
    Allen B; Harocopos A
    J Subst Abuse Treat; 2016 Nov; 70():81-86. PubMed ID: 27692193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.